KATP channels mediate the β2-adrenoceptor agonist-induced relaxation of rat detrusor muscle

2000 ◽  
Vol 397 (1) ◽  
pp. 169-176 ◽  
Author(s):  
Diane Hudman ◽  
Ruth A Elliott ◽  
Robert I Norman
2008 ◽  
Vol 15 (12) ◽  
pp. 1072-1076 ◽  
Author(s):  
Atsushi Otsuka ◽  
Hitoshi Shinbo ◽  
Ko Hasebe ◽  
Rikiya Matsumoto ◽  
Seiichiro Ozono

2004 ◽  
Vol 286 (3) ◽  
pp. E463-E471 ◽  
Author(s):  
Andrea Sieg ◽  
Jiping Su ◽  
Alvaro Muñoz ◽  
Michael Buchenau ◽  
Mitsuhiro Nakazaki ◽  
...  

This study examines the effect of epinephrine, a known physiological inhibitor of insulin secretion, on the membrane potential of pancreatic islet cells from sulfonylurea receptor-1 (ABCC8)-null mice (Sur1KO), which lack functional ATP-sensitive K+ (KATP) channels. These channels have been argued to be activated by catecholamines, but epinephrine effectively inhibits insulin secretion in both Sur1KO and wild-type islets and in mice. Isolated Sur1KO β-cells are depolarized in both low (2.8 mmol/l) and high (16.7 mmol/l) glucose and exhibit Ca2+-dependent action potentials. Epinephrine hyperpolarizes Sur1KO β-cells, inhibiting their spontaneous action potentials. This effect, observed in standard whole cell patches, is abolished by pertussis toxin and blocked by BaCl2. The epinephrine effect is mimicked by clonidine, a selective α2-adrenoceptor agonist and inhibited by α-yohimbine, an α2-antagonist. A selection of K+ channel inhibitors, tetraethylammonium, apamin, dendrotoxin, iberiotoxin, E-4130, chromanol 293B, and tertiapin did not block the epinephrine-induced hyperpolarization. Analysis of whole cell currents revealed an inward conductance of 0.11 ± 0.04 nS/pF ( n = 7) and a TEA-sensitive outward conductance of 0.55 ± 0.08 nS/pF ( n = 7) at -60 and 0 mV, respectively. Guanosine 5′- O-(3-thiotriphosphate) (100 μM) in the patch pipette did not significantly alter these currents or activate novel inward-rectifying K+ currents. We conclude that epinephrine can hyperpolarize β-cells in the absence of KATP channels via activation of low-conductance BaCl2-sensitive K+ channels that are regulated by pertussis toxin-sensitive G proteins.


2007 ◽  
Vol 177 (4S) ◽  
pp. 556-557 ◽  
Author(s):  
Daniel M. Schmid ◽  
Peter Sauermann ◽  
Matthias Werner ◽  
Daniele Perucchini ◽  
Tullio Sulser ◽  
...  

2005 ◽  
Vol 173 (4S) ◽  
pp. 45-45 ◽  
Author(s):  
Catherine A. Thomas ◽  
Shachi Tyagi ◽  
Hitoshi Masuda ◽  
Naoki Yoshimura ◽  
Michael B. Chancellor ◽  
...  

1992 ◽  
Vol 68 (06) ◽  
pp. 687-693 ◽  
Author(s):  
P T Larsson ◽  
N H Wallén ◽  
A Martinsson ◽  
N Egberg ◽  
P Hjemdahl

SummaryThe significance of platelet β-adrenoceptors for platelet responses to adrenergic stimuli in vivo and in vitro was studied in healthy volunteers. Low dose infusion of the β-adrenoceptor agonist isoprenaline decreased platelet aggregability in vivo as measured by ex vivo filtragometry. Infusion of adrenaline, a mixed α- and β-adrenoceptor agonist, increased platelet aggregability in vivo markedly, as measured by ex vivo filtragometry and plasma β-thromboglobulin levels. Adrenaline levels were 3–4 nM in venous plasma during infusion. Both adrenaline and high dose isoprenaline elevated plasma von Willebrand factor antigen levels β-Blockade by propranolol did not alter our measures of platelet aggregability at rest or during adrenaline infusions, but inhibited adrenaline-induced increases in vWf:ag. In a model using filtragometry to assess platelet aggregability in whole blood in vitro, propranolol enhanced the proaggregatory actions of 5 nM, but not of 10 nM adrenaline. The present data suggest that β-adrenoceptor stimulation can inhibit platelet function in vivo but that effects of adrenaline at high physiological concentrations are dominated by an α-adrenoceptor mediated proaggregatory action.


Author(s):  
Ada Admin ◽  
Michelle Carey ◽  
Eric Lontchi-Yimagou ◽  
William Mitchell ◽  
Sarah Reda ◽  
...  

Hyperglycemia is a potent regulator of endogenous glucose production (EGP). Loss of this ‘glucose effectiveness’ is a major contributor to elevated plasma glucose concentrations in type 2 diabetes (T2D). ATP-sensitive potassium channels (K<sub>ATP</sub> channels) in the central nervous system (CNS) have been shown to regulate EGP in humans and rodents. We examined the contribution of central K<sub>ATP</sub> channels to glucose effectiveness. Under fixed hormonal conditions (‘pancreatic clamp’ studies), hyperglycemia suppressed EGP by ~50% in both non-diabetic humans and normal Sprague Dawley rats. By contrast, antagonism of K<sub>ATP</sub> channels with glyburide significantly reduced the EGP-lowering effect of hyperglycemia in both humans and rats. Furthermore, the effects of glyburide on EGP and gluconeogenic enzymes in rats were abolished by intracerebroventricular (ICV) administration of the KATP channel agonist diazoxide. These findings indicate that about half of EGP suppression by hyperglycemia is mediated by central K<sub>ATP</sub> channels. These central mechanisms may offer a novel therapeutic target for improving glycemic control in T2D.


Sign in / Sign up

Export Citation Format

Share Document